First test of new antibody for tick-borne encephalitis
Part of Brain & nervous system, Infections clinical trials.
This study tests a new experimental antibody treatment for tick-borne encephalitis in healthy people. It is the first time this treatment is given to humans, to see if it is safe and how the body handles it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 54 years old
- Be generally healthy with no major medical conditions
- Not be pregnant, breastfeeding, or planning to father a child during the study
- Have a body mass index (BMI) between 19 and 30
- Not have HIV, active hepatitis B, or hepatitis C
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new ways to find the cause of lymphocytic meningitis or meningoencephalitis (inflammation of the brain or its lining) when standard tests don't give an answer. It may help people who have been hospitalized with these conditions and whose spinal fluid tests were unclear or not done.
This study looks at the cost and effectiveness of the tick-borne encephalitis vaccine. It will also track the recovery of patients hospitalized with confirmed tick-borne encephalitis to understand the long-term impact of the disease.
This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.
This study looks at blood antibody test results in adults who may have tick-borne encephalitis and also signs of Lyme disease. It may help researchers understand how these infections relate and which lab patterns fit different illnesses.
This study looks at how a person’s immune system responds after exposure to Ixodes (black-legged) tick bites. It aims to better understand the body’s early immune reaction after tick exposure, using blood tests and small skin samples.
This trial tests a new lab-made antibody to prevent rabies after exposure. It is for healthy volunteers who have not gotten a rabies vaccine or been exposed to rabies before.
Hear when a new The Tick-borne Encephalitis Virus (TBEV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.